通过对膜关联性质的分析揭示了Aβ的生物功能:对阿兹海默病病原发生的影响
Meewhi Kim1, Ilya Bezprozvanny2
1Dept of Physiology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.
Biochemical and biophysical research communications
|September 2, 2024
概括
涉及阿尔茨海默氏病 (AD) 的胺β与细胞膜相互作用. 这种相互作用类似于抗微生物,可以解释与Aβ42,FAD突变和胆固醇相关的突触缺陷.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 粉样蛋白前体蛋白 (APP) 处理是阿尔茨海默病 (AD) 发病过程的核心.
- 通过β和γ分泌酶切割APP,产生Aβ40和Aβ42,Aβ42与毒性有关.
- 对于Aβ的生物学作用和毒性机制的理解尚不完全.
研究的目的:
- 调查Aβ与内体膜相关的生物学意义.
- 描述Aβ的膜关联区域 (E682-N698) 的特征.
- 探索FAD突变和胆固醇如何影响Aβ膜相互作用.
主要方法:
- 与已知的抗微生物 (AMP) 的Aβ皮质膜关联的比较分析.
- 对Aβ40和Aβ42的围膜关联能量的评估.
- 评估FAD突变和胆固醇对Aβ膜结合的影响.
主要成果:
- Aβ区E682-N698表现出类似于AMP的膜关联.
- Aβ40显示的膜关联比Aβ42或AMPs更弱.
- Aβ的膜关联是由FAD突变和胆固醇增强的.
结论:
- Aβ可以改变内体膜曲率,影响内体贩运通路.
- 这种由FAD突变或胆固醇增强的机制,为AD中的突触缺陷提供了潜在的解释.
- 这些发现提供了Aβ42,FAD突变,胆固醇和AD相关的突触功能障碍之间的机制联系.
相关概念视频
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Ligand-gated Ion Channels
12.3K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.3K


